Table: Jcr Pharmaceuticals -Q1 group results

JCR Pharmaceuticals

30/07/2024 08:00

Jul 30 (Reuters)- 
             Jcr Pharmaceuticals Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               8.15                10.81            41.30    
                   (-24.6 pct)         (+12.5 pct)      (-3.7 pct)  
  Operating       loss 296 mln             2.07             5.40    
                                       (+34.5 pct)      (-28.3 pct) 
  Recurring       loss 257 mln             2.26             4.60    
                                       (+8.5 pct)       (-36.7 pct) 
  Net                201 mln               1.61             3.70    
                   (-87.5 pct)         (+17.7 pct)      (-32.8 pct) 
  EPS               1.61 yen            12.91 yen        29.65 yen  
  EPS Diluted       1.61 yen            12.85 yen                   
  Ann Div                               20.00 yen        20.00 yen  
  -Q2 div                               10.00 yen        10.00 yen  
  -Q4 div                               10.00 yen        10.00 yen  
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T